Literature DB >> 8095543

Determination of salmeterol in rat and dog plasma by high-performance liquid chromatography with fluorescence detection.

P V Colthup1, G C Young, C C Felgate.   

Abstract

Salmeterol (as the hydroxynaphthoate) is the first of a new class of long-acting beta-adrenergic receptor agonists with both bronchodilator and anti-inflammatory actions. A sensitive, accurate, and precise high-performance liquid chromatographic method for the determination of salmeterol in rat and dog plasma is described. Samples are prepared by solid-phase extraction and, after chromatography of the extracts on a reversed-phase styrene/divinylbenzene analytical column, salmeterol is detected by fluorescence monitoring (excitation wavelength, 230 nm; emission wavelength, 305 nm). The method is sensitive to 1 ng/mL, at which concentration the coefficient of variation was 16.3% in a single assay run. Repeated analyses of quality control samples, nominally at 2 ng/mL, were carried out over a number of assay runs with a coefficient of variation of 10.4%. The method is specific for salmeterol with respect to endogenous plasma components and identified metabolites. The assay was applied to the analysis of salmeterol in plasma of rats and dogs from pharmacokinetic studies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095543     DOI: 10.1002/jps.2600820321

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

Review 1.  Clinical pharmacokinetics of salmeterol.

Authors:  Mario Cazzola; Renato Testi; Maria Gabriella Matera
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Molecular Dynamic Study of Mechanism Underlying Nature of Molecular Recognition and the Role of Crosslinker in the Synthesis of Salmeterol-Targeting Molecularly Imprinted Polymer for Analysis of Salmeterol Xinafoate in Biological Fluid.

Authors:  Shendi Suryana; Mutakin Mutakin; Yudi Rosandi; Aliya Nur Hasanah
Journal:  Molecules       Date:  2022-06-05       Impact factor: 4.927

3.  HPTLC-densitometric method for simultaneous determination of salmeterol xinafoate and fluticasone propionate in dry powder inhalers.

Authors:  Lantider Kasaye; Ariaya Hymete; Abdel-Maaboud I Mohamed
Journal:  Saudi Pharm J       Date:  2010-05-31       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.